5Y Capital

5Y Capital is a private equity and venture capital firm based in Shanghai, China, specializing in seed, startup, early venture, and growth capital investments. Established in 1992, the firm focuses on a diverse range of sectors, including healthcare, technology, fintech, internet services, consumer services, media, and life sciences, among others. It aims to support entrepreneurs in building innovative companies, particularly in China and other emerging markets in Asia/Pacific. Managing approximately USD 5 billion in dual-currency funds, 5Y Capital attracts investments from global sources, including sovereign wealth funds and family offices. The firm typically makes initial investments exceeding USD 500,000 per portfolio company. 5Y Capital operates under the Morningside Group, which is committed to socially responsible investing, particularly in educational opportunities and scientific research.

W. Anthony Brooke

Director

Zhe Chen

Managing Director

Peter Chen

Managing Director

Yu Cheng

Partner

Ziyou Fu

Investor Relations Professional

Hanson Hu

Investment Manager

Lu Huang

Director

Ted Xutian Jing

Managing Director

Levi Liu Kai

Partner

Yantao Lai

Investment Manager

Wentian Lian

VP

Tony Lian

Investment Manager

Sylvia Liu

Investment Manager

Qin Liu

Co-Founder, Investment Director & Board Member

Richard Liu

Founding Partner

Richard Liu

Founding Partner

Weimin Luo

Partner and Senior Consultant

Ken Shi

Founding Partner

Jianming Shi

Director of Business Development

Kejia Tang

Human Resource Director

Ji Tong

Investment Manager

Sixue Wang

Public Relations and Investor Relations Professional

Qiong Xue

CFO

Joanna Xue

Chief Financial Officer

Dan You

Executive Director

Cloris You Youdan

Managing Director

Elwin Yuan

Partner

Ye Yuan

Partner

Oliver Zhang

Investment Manager

Fisher Zhang

Partner

Fei Zhang

Partner

Bo Zhang

Managing Director

Past deals in Series B

evonetix

Series B in 2023
Evonetix Ltd is a biotechnology company based in Little Chesterford, United Kingdom, founded in 2015. The company focuses on developing innovative technology for the parallel synthesis of DNA on silicon arrays, which supports advancements in synthetic biology. Situated within the prestigious Cambridge cluster of high-tech and life science organizations, Evonetix aims to revolutionize DNA synthesis through novel techniques that enhance efficiency and capability. The team at Evonetix comprises experienced professionals from various scientific and engineering disciplines, bringing together a wealth of knowledge to drive the commercialization of their technology.

LANDBASE

Series B in 2022
LANDBASE is a food brand management company driven by the concept of innovation & fashion. Committed to integrating global R&D and production resources, LANDBASE utilizes frontier food processing technologies to redefine traditional foods and build fashionable foods for the future.

Airspace Link

Series B in 2022
Airspace Link digitizes local airspace for urban air mobility. It provides government, citizen, and business drone solutions to support local government airspace management, fostering citizen empowerment, and business innovation through consumer and b2b air logistical support and services. It was founded in 2018 and is based in Detroit, Michigan.

XYZ Robotics

Series B in 2022
XYZ Robotics develops AI-enabled robotic perception and manipulation technology for logistics and manufacturing automation. The company develops autonomous robotic solutions for put wall sorting and goods-to-person picking. Its robot sorts unorganized, random warehouse goods into groups of customer orders. The solution embodies its strength in deep learning and robotics.

METiS Therapeutics

Series B in 2022
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.

Virtue Diagnostics

Series B in 2022
VIRTUE Diagnostics(Suzhou)Co.,Ltd. develops in vitro diagnostic platform. The company offers technology platforms including clinical mass spectrometry, multiplex immunohistochemistry for pathology-based cancer detection, and a molecular and immunoassay platform. VIRTUE Diagnostics(Suzhou)Co.,Ltd. was founded in 2019 and is based in Suzhou, China with a research and development office in Singapore.

Xbiome

Series B in 2021
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Vastai Technologies

Series B in 2021
Vastai Technologies is focused on developing AI chips for the optimization of computer vision and video processing.

ieso

Series B in 2021
Ieso Digital Health Ltd. specializes in providing online evidence-based cognitive behavioral therapy (CBT) to individuals facing various mental health challenges, including anxiety and depression. The company's unique online service facilitates real-time communication between accredited therapists and patients through a secure virtual environment, where sessions are conducted via text. This approach not only mirrors traditional face-to-face interactions but also offers greater convenience for users. Ieso began its operations in the UK in 2000 and has since expanded into the US market, collaborating with Medicaid and commercial health plans to enhance access to mental health services. The company’s therapy model has demonstrated effectiveness, requiring fewer sessions to achieve recovery and showing improved outcomes compared to conventional therapy methods. Ieso serves a diverse clientele, including health providers, private individuals, and businesses, and is recognized for its rapid growth in the digital health sector.

Generate Biomedicines

Series B in 2021
Generate Biomedicines, Inc. develops a platform to invent novel antibodies, peptides, enzymes, receptors, and other therapeutic proteins. It offers Generative Biology, a machine learning based solution that learns from all known proteins in order to encode and apply the fundamental principles of how genetic sequences lead to protein structure and function for creating novel protein sequences with optimized therapeutic potential. Its Generative Biology is applied to all protein modalities and generate novel proteins with desired functions and solutions that interact potently and specifically with therapeutic targets. Generate Biomedicines, Inc. was formerly known as Generate Biologics, Inc. and changed its name to Generate Biomedicines, Inc. in March 2020. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Axbio

Series B in 2021
Axbio Inc. develops and manufactures technology for genetic sequencing. It offers products, such as stool genome extraction kit, blood genome extraction kit, saliva genome extraction kit, and bacterial genome extraction kit. The company provides sequencing and diagnostic systems, disposable biochips, and reagents. Axbio Inc. was founded in 2016 and is based in Shenzhen, China.

Homee

Series B in 2021
Homee, Inc. provides a mobile application that connects enterprises, customers, and service providers in a home service transaction. Its technology platform allows users to find and hire handyman, plumbers, electricians, HVAC service providers, and others. The company serves homeowners, renters, and property managers. Homee, Inc. was founded in 2017 and is based in Tampa, Florida.

Etern

Series B in 2021
Etern is developing small molecule innovative drugs for oncology therapies.

Bota Biosciences

Series B in 2021
Bota Biosciences designs and develops synthetic bioengineering technology platform for bio-manufacturing. The company develops cloud databases and intelligent control software suitable for biotechnology development and production. Bota Biosciences was founded in 2019 and is based in Hangzhou, China.

XYZ Robotics

Series B in 2021
XYZ Robotics develops AI-enabled robotic perception and manipulation technology for logistics and manufacturing automation. The company develops autonomous robotic solutions for put wall sorting and goods-to-person picking. Its robot sorts unorganized, random warehouse goods into groups of customer orders. The solution embodies its strength in deep learning and robotics.

Block Renovation

Series B in 2021
Block Renovation is a renovation platform that combines architect-grade design, construction labor, and materials into a streamlined renovation experience. Block’s mission is to give homeowners a better way to improve the spaces they live in, and to give contractors a better way to work. Founded by Koda Wang and Luke Sherwin, Block simplifies a complex and convoluted process and delivers an intuitive experience for completing a beautiful home renovation.

Triastek

Series B in 2021
Triastek Co. Ltd. manufactures 3D printed pharmaceuticals and related medical equipment. It offers blockbuster drugs, orphan drugs, and complex drug delivery technologies. It also offers drug 3D printing, such as three-dimensional drug structure formulation design, 3D printing pharmaceutical equipment, and drug product development methods for patent families in China, US, Europe, and Japan. The company also owns Melt Extrusion Deposition (MED), a 3D printing technology universally applicable to solid formulations. The company was founded in 2015 and is based in Nanjing, China.

Alentis Therapeutics

Series B in 2021
Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, focused on developing novel treatments for advanced liver diseases. Founded in 2019, the company aims to address conditions such as liver fibrosis, cirrhosis, and liver cancer, particularly targeting Claudin-1 positive tumors and organ fibrosis. Alentis employs a research platform that utilizes clinically relevant readouts and single-cell RNA sequencing of patient liver tissues, enabling the development of effective therapies to combat fibrosis and reverse the progression of these diseases. Through its innovative approach, Alentis Therapeutics seeks to improve outcomes for patients suffering from severe liver-related health issues.

Coin Metrics

Series B in 2021
Coin Metrics Inc. is an online publisher specializing in blockchain and cryptocurrency data, offering a range of market and network analytics to various industries. Founded in 2017 and based in Cambridge, Massachusetts, the company provides several key products, including the CM Network Data Pro, which delivers historical crypto network data in a detailed format for institutional clients. Additionally, Coin Metrics offers the CM Market Data Feed, a standardized solution for trade, candle, and order book data from multiple exchanges, and CM Reference Rates, which provides fixed pricing for various assets quoted in U.S. dollars. By focusing on transparent and actionable data, Coin Metrics enables stakeholders to better understand and utilize public crypto networks.

HAI ROBOTICS

Series B in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in developing autonomous case-handling robotic systems for warehouse automation. The company offers a range of intelligent automation solutions, including a goods-to-person system, smart in-plant logistics, and multi-tier steel platform solutions, suitable for diverse operational scenarios. HAI ROBOTICS is a pioneer in the field, having launched its first autonomous case-handling robot, HAIPICK, in 2015. The HAIPICK system has demonstrated significant advantages, enhancing warehouse operational efficiency by three to four times and increasing storage density by 80% to 130%. The company is committed to research and development, holding numerous patents and continuously improving its products to meet the needs of a growing customer base, which includes major clients like DHL Supply Chain, BEST Supply Chain, and Philips. With the capability to deploy automation solutions within a week, HAI ROBOTICS aims to optimize warehousing operations through advanced robotics and artificial intelligence.

SoupMaster

Series B in 2021
SoupMaster is a Chinese restaurant chain and retail brand. It provides various nutritious soups for pregnant women, patients with a demand for health recuperation, and other people pursuing high-quality life.

Arctic Vision

Series B in 2021
Arctic Vision (Shanghai) Biotechnology Co., Ltd. is a clinical-stage specialty ophthalmology company based in China, focused on developing innovative therapies to meet the unmet clinical needs in ophthalmic diseases. The company has a portfolio of breakthrough technologies aimed at addressing various eye care challenges, including rare diseases through gene therapy. Established by prominent life sciences investors, Arctic Vision is led by a team of experienced professionals from the ophthalmic industry, bringing extensive expertise in research, development, and commercialization of eye care products. The company aims to deliver effective solutions not only in China but also across Asia and globally.

Liran cosmetics

Series B in 2021
Liran cosmetics operates as a men’s personal care brand. Liran cosmetics provides products catered to men covering skincare, body wash, hair care, body fragrance, and makeup, among others.

Xbiome

Series B in 2020
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Gongsibao

Series B in 2020
Gongsibao provides an O2O enterprise service platform. Gongsibao was founded in 2014 and is based in Chaoyang, China.

Zilliz

Series B in 2020
Zilliz is a technology company founded in 2017 and headquartered in San Francisco, California, with additional offices in China. It specializes in developing an intelligent data processing platform that enhances query performance, utilizing GPU hardware acceleration. Zilliz is renowned for its open-source project Milvus, which focuses on AI-powered unstructured data analysis and vector similarity search. Since its release in 2019, Milvus has gained significant traction, attracting over 400 enterprise users and engaging more than 120 contributors on GitHub. Its applications are diverse, encompassing areas such as image processing, computer vision, natural language processing, speech recognition, recommendation engines, and drug development. In 2020, Milvus became an incubation-stage project at the LF AI & Data Foundation, reflecting its active development and community support.

Revolo Biotherapeutics

Series B in 2020
Revolo Biotherapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory and immunological diseases, such as asthma, atopic dermatitis, and inflammatory bowel disease. The company's approach is grounded in the natural mechanisms employed by Mycobacterium tuberculosis to evade the host immune system, allowing it to suppress inflammatory responses. Unlike existing treatments that aim to suppress the immune system and often require chronic dosing with significant side effects, Revolo's immune-resetting therapies have shown promise in preclinical and human studies by safely transitioning the immune system from a pro-inflammatory state to a regulatory one. This novel strategy aims to induce long-term disease remission without the adverse effects typically associated with conventional therapies. Founded in 2001 and based in London, Revolo Biotherapeutics is dedicated to transforming the treatment landscape for patients suffering from allergic and immune-mediated conditions.

Amylyx Pharmaceuticals

Series B in 2020
Amylyx Pharmaceuticals, Inc. develops novel therapeutic for Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. It offers AMX0035, an investigational therapy and a fixed-dose co-formulation of two active compounds, such as sodium phenylbutyrate and Taurursodiol optimized to treat both the energy crisis in the mitochondria and the toxic, unfolded proteins in the endoplasmic reticulum, disrupting the neurological chain of events that leads to patient suffering. The company’s pipeline includes amyotrophic lateral sclerosis, Wolfram syndrome, and Alzheimer’s diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is based in Cambridge, Massachusetts.

Polaris Biology

Series B in 2020
Shanghai Polaris Biology Co., Ltd. develops a cell diagnostic technology platform for tumors. Its platform combines artificial intelligence (AI)-based cell analysis models and analyzes dynamic changes of tumors at the cell level. The data collected supports clinical tumor diagnosis and treatment. Shanghai Polaris Biology Co., Ltd. was founded in 2016 and is based in Shanghai, China.

Big Health

Series B in 2020
Big Health is a London-based company that develops and markets digital healthcare solutions focused on improving mental health and sleep disorders. Its flagship product, Sleepio, is a digital sleep improvement program that utilizes Cognitive Behavioral Therapy techniques to address individual sleep challenges. The platform offers fully-automated, personalized therapeutic sessions, allowing users to engage with their specific issues and track their progress. In addition to Sleepio, Big Health provides a broader digital healthcare portal that delivers customized behavioral programs aimed at various mental health concerns, all designed in consultation with medical professionals to ensure efficacy and relevance.

evonetix

Series B in 2020
Evonetix Ltd is a biotechnology company based in Little Chesterford, United Kingdom, founded in 2015. The company focuses on developing innovative technology for the parallel synthesis of DNA on silicon arrays, which supports advancements in synthetic biology. Situated within the prestigious Cambridge cluster of high-tech and life science organizations, Evonetix aims to revolutionize DNA synthesis through novel techniques that enhance efficiency and capability. The team at Evonetix comprises experienced professionals from various scientific and engineering disciplines, bringing together a wealth of knowledge to drive the commercialization of their technology.

ONES.com

Series B in 2019
ONES.AI is a technology company that provides enterprise-level R&D management solutions. ONES.AI tools include ONES Project for project progress management; ONES Plan for program management; ONES Wiki for repository management); ONES TestCase for test case and test plan management; and ONES Pipeline for continuous integration and delivery management. It has provided services to more than 20,000 enterprises and organizations including People's Daily New Media, Hi Tea, Kingsoft, HKUST Xunfei, and SASAC Research Center. It has mature solutions in the fields of new retail, games, live broadcast, fintech, artificial intelligence, and other fields. ONES.AI was founded in 2015.

Xbiome

Series B in 2019
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

GalaxySpace

Series B in 2019
GalaxySpace develops and builds LEO broadband satellite constellation, and 5G communication network. The company’s satellite applications include monitoring of airport, parking, and oil reserves, as well as assess land types and uses. GalaxySpace was founded in 2016 and is based in Haidian, China.

Inotrem

Series B in 2019
Inotrem S.A. is a biotechnology company based in Paris, France, specializing in the discovery and development of innovative treatments for inflammatory pathologies, particularly in critical care settings. Founded in 2013, the company focuses on immunotherapy and has created a novel immunomodulation approach targeting the TREM-1 pathway to manage excessive inflammation. Its lead product, nangibotide (also known as LR12), is a first-in-class TREM-1 inhibitor designed to address severe conditions such as septic shock and myocardial infarction. Inotrem is also advancing a program aimed at treating chronic inflammatory diseases, leveraging its proprietary technology platform to develop new therapeutic modalities.

Medannex Ltd

Series B in 2019
MedAnnex Limited is a biotechnology company based in Edinburgh, United Kingdom, focused on developing innovative treatments for patients with autoimmune diseases and cancers. Established in 2009, the company is known for its lead product, annexuzlimab, a monoclonal antibody designed to address various autoimmune conditions. MedAnnex aims to create first-in-class antibody therapies that significantly enhance the quality of life for individuals affected by these serious health issues. Through its research and development efforts, the company is committed to advancing therapeutic options in the biotechnology sector.

XtalPi

Series B in 2019
XtalPi Inc. is a pharmaceutical technology company founded in 2014 and headquartered in Cambridge, Massachusetts, with additional offices in China. The company specializes in leveraging artificial intelligence and advanced computing to accelerate drug development. Its offerings include XtalForc, a visual force field calculation software; XtalVision, a tool for crystal structure prediction; and Renova, which supports AI-driven research and development. XtalPi provides a range of services such as crystal structure prediction and determination, solid state testing and analysis, crystallization process development, and small molecule drug design. By collaborating with pharmaceutical companies, XtalPi uses its predictive algorithms to facilitate the development of new drugs and the creation of patents, enhancing the efficiency of the drug discovery process.

Zmjiudian

Series B in 2019
Zmjiudian is a startup company dedicated to the recommendation and reservation of surrounding resort hotels. It is dedicated to business travellers, leisure and holiday users to integrate suitable housing resources, and has a product weekend hotel app, which is a platform for hotel accommodation.

CollegeVine

Series B in 2019
CollegeVine provides mentorship, college applications guidance, college essay assistance, tutoring, and test preparation consulting services. The company was formerly known as Admissions Hero LLC and changed its name to CollegeVine in August 2016. CollegeVine was founded in 2013 and is based in Cambridge, Massachusetts.

Horizon Robotics

Series B in 2019
Beijing Horizon Robotics Technology Co., Ltd. develops chips for robots. The company was founded in 2015 and is based in China.

Shukun Technology

Series B in 2019
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.

Kuaidian Yuedu

Series B in 2018
Kuaidian Yuedu offers a story reading app.

Thunder Stone Technology

Series B in 2018
Beijing ThunderStone Technology Co., Ltd. is the largest karaoke system supplier in China. It has 40% of the market share. China is one of the largest and matured karaoke markets in the world. A typical system consists of one or more VOD servers which based on Windows 2000 server edition and multiple STBs in karaoke rooms. They are all connected to the server or servers via Ethernet. The server is efficient and robust. A single server can support up to 60 DVD quality videos and audio streams.

Genedock

Series B in 2018
Founded in September 2014, GeneDock is a national high-tech enterprise dedicated to the development of precision medical data technology. It has the industry-leading experience in building medical data platforms, providing medical, scientific research institutions and enterprises with a comprehensive platform for building data platforms. Pratt & Whitney's precision medical applications use data technology to drive innovation in the health care sector. At present, it has provided group data platform services for dozens of domestic top three hospitals, top industry institutions and enterprises including Southwest Hospital, Xinhua Hospital and Huada Science and Technology; core members are from well-known enterprises such as Alibaba and Huada Gene; Jingwei China, Puhua Capital, Shell Society, Lenovo Star and other well-known investment institutions invest.

Xpeng Motors

Series B in 2018
Xiaopeng Motors is an electric vehicle and technology company that designs and manufactures smart cars. Xiaopeng Motors focuses on local needs and the consumer experience, while also integrating autonomous driving and internet electronic technologies, their vehicles are greater than the sum of their parts. Xpeng Motors is not only dedicated to serving every family with technology but also to become a companion that truly understands you. Xpeng is equipped with experts from top companies in the field such as Tesla, Mercedes-Benz, Porsche, Ford, Mazda, GAC Motor, Alibaba Group, Tencent, Huawei, P&G and Mi, and more. Electric cars, the Internet, and cross-border brand-retail and internet integration have made Xpeng the main pioneer of this industry.

Peach

Series B in 2018
Peach Labs, Inc. specializes in delivering lunch from local restaurants to businesses in several metropolitan areas, including Greater Seattle, Boston, and Phoenix. Founded in 2014 and headquartered in Seattle, the company facilitates a convenient lunch benefit program by sending customers a text message containing a menu of daily offerings from partnered restaurants. Customers can place orders for themselves or groups through a simple text reply or online. This service aims to enhance workplace productivity by providing wholesome and fulfilling meals directly to office locations, and it has gained recognition as one of the top start-ups in the Pacific Northwest.

Hang

Series B in 2018
Agora, Inc. is a provider of Real-Time Engagement Platform-as-a-Service (RTE-PaaS) that enables developers to incorporate real-time video, voice, and messaging capabilities into their applications. Founded in 2013 and headquartered in Shanghai, the company offers a range of enterprise-grade products, including features for live interactive video and audio streaming, real-time messaging, and recording. Agora's solutions cater to various sectors such as social media, education, entertainment, gaming, healthcare, and financial services. The company operates a Software-Defined Real-Time Network, enhancing the delivery of its services across the globe. Additionally, Agora Lab, founded in 2014 and based in Palo Alto, California, focuses on developing real-time communication solutions, particularly in gaming and social networking. The Agora platform is recognized for its reliability and scalability, making it a widely adopted choice for organizations seeking efficient communication solutions.

Haohaozhu

Series B in 2018
Haohaozhu is a Beijing-based company founded in 2015 that operates an online platform and mobile application dedicated to home improvement and interior design. The platform provides users with access to various decoration solutions tailored to their homes, while also connecting them to sellers. Additionally, it fosters a social community where users can share images and information related to home design.

Creams

Series B in 2018
Creams is a SaaS building asset management platform.

BestSign

Series B in 2018
BestSign is a provider of electronic contract lifecycle services that aims to enhance transaction efficiency through the use of blockchain technology. Founded in 2017 and headquartered in Hangzhou, China, BestSign offers a platform that delivers reliable and user-friendly eSignature cloud services. These services encompass online signing, contract storage and management, as well as litigation support and insurance compensation. By leveraging the benefits of decentralization, BestSign enables enterprises across various sectors such as Internet finance, commercial real estate, online education, and e-commerce to improve their operational efficiency, reduce delivery costs, and implement effective digital contract management solutions.

Xpeng Motors

Series B in 2018
Xiaopeng Motors is an electric vehicle and technology company that designs and manufactures smart cars. Xiaopeng Motors focuses on local needs and the consumer experience, while also integrating autonomous driving and internet electronic technologies, their vehicles are greater than the sum of their parts. Xpeng Motors is not only dedicated to serving every family with technology but also to become a companion that truly understands you. Xpeng is equipped with experts from top companies in the field such as Tesla, Mercedes-Benz, Porsche, Ford, Mazda, GAC Motor, Alibaba Group, Tencent, Huawei, P&G and Mi, and more. Electric cars, the Internet, and cross-border brand-retail and internet integration have made Xpeng the main pioneer of this industry.

Soul

Series B in 2018
SOUL is a social network that uses AI to help users find their soul mates.

Etong Healthcare

Series B in 2017
EtongOnline Shanghai Medical Consulting provides third-party health management services to large and medium-sized enterprises in Shanghai, Beijing, Shenzhen, Guangzhou, Wuhan, & Chengdu. Its healthy management services include file recording, health assessment, health intervention, health education, health consultation, and private doctor services. The company also provides health examination services, such as employment health check, physical examination, PET-CT testing, gene detection, and enterprise welfare health check services. In addition, it offers medical services, such as medical guidance, specialist appointment, admission solutions, surgery appointment, secondary consultation, and particular examination arrangement services. Further, the company provides services in the areas of establishment of health infirmary, enterprise stratified health management, overseas medical, medical tourism, liability insurance, and oral care. EtongOnline Shanghai Medical Consulting was founded in 2009 and is headquartered in Shanghai City, China.

Zhuiyi Technology

Series B in 2017
Zhuiyi Technology is an artificial intelligence company based in Shenzhen, China, specializing in deep learning and natural language processing. The firm develops AI solutions, including a chatbot named YiBot, designed to facilitate interactions between humans and enterprises. Its offerings encompass AI services for semantics, speech, and vision, enabling businesses to enhance customer service, conduct big data analysis, and deliver personalized services. Zhuiyi Technology's AI digital employee intelligence platform can be tailored for various business scenarios, supporting corporate and government functions in marketing, operations, and office tasks. The company serves a diverse range of industries, including finance, Internet, tourism, retail, real estate, and education, positioning itself as a key player in the field of enterprise intelligent services.

Kezar Life Sciences

Series B in 2017
Kezar Life Sciences, Inc. is a clinical-stage biotechnology company based in South San Francisco, California, focused on developing novel small molecule therapeutics for unmet medical needs in autoimmunity and cancer. The company’s lead candidate, KZR-616, is a selective immunoproteasome inhibitor currently undergoing Phase 2 clinical trials for multiple autoimmune conditions, including lupus nephritis and autoimmune hemolytic anemia, as well as Phase 1b/2 trials for systemic lupus erythematosus. In addition to KZR-616, Kezar is advancing preclinical products, including KZR-TBD, aimed at treating oncology and autoimmune disorders. Founded in 2015, Kezar Life Sciences leverages insights into protein homeostasis, particularly the interplay between protein degradation and secretion, to drive its drug discovery efforts.

Freight Farms

Venture Round in 2017
Freight Farms, Inc. specializes in manufacturing hydroponic crop production units constructed from up-cycled shipping containers. Their flagship product, the Leafy Green Machine, is a pre-assembled system that enables commercial-scale production of various crops, including herbs like mint and basil, as well as lettuces and brassicas such as kale and cabbage, regardless of climate or season. Founded in 2010 and based in Boston, Massachusetts, the company aims to enhance food accessibility in regions where traditional farming is challenging. By facilitating high-yield crop production, Freight Farms supports the development of local food economies and sustainable food systems for a diverse clientele, including business owners, farmers, educational institutions, municipalities, and non-profits across the United States, Canada, and Europe.

Xiaolu Clinic

Series B in 2017
Xiaolu Clinic is an online platform connecting traditional Chinese medicine providers with consumers. It offers online traditional Chinese medicine consultancy services for patients with chronic disease and those suffering from sub-optimal health, areas that traditional Chinese medicine might treat with herbal mixtures and dietary augmentation. Users can be evaluated by traditional Chinese medicine doctors and purchase herbal remedies online, as well as engage in treatment monitoring and post-treatment analysis. It also provides health management services for staff at big companies, including Baidu Inc., China Life Insurance (Group) Co., and Tencent Holdings Ltd. The Beijing-based company was founded in 2016.

Elysium

Series B in 2016
Elysium Health offers health products built with science such as dietary supplements and anti-aging drugs. It seeks to solve challenges in health with science, to help people live healthier and longer lives. It works directly with the scientists, clinicians, and health professionals around the world to identify and develop the natural compounds. Its product is a proprietary formulation of two ingredients designed to support long-term well-being at the cellular level.

Huimin

Series B in 2016
Huimin is a B2B e-commerce platform that focuses on small-scale supermarkets that provides community supermarket websites for communities. It is a national modern service industry demonstration unit, leading a brand of domestic community B2B e-commerce, Internet, entity, and people's livelihood. The company integrates the resources of the national community supermarket and encourages the community and innovates value through the Internet platform and technology. Huimin was founded in May 2013 and is headquartered in Beijing, China.

Shengong007

Series B in 2016
Shengong007 is a home decoration service platform.

Shengong Zhongzhi Science & Technology Company

Series B in 2016
Shengong Zhongzhi Science & Technology Company is home furnishing service provider
Smartmi, established in 2014, is focused on designing and manufacturing smart home appliances. They are constantly improving product design and pushing forward technological innovation to interconnect smart appliances, and let users experience the beauty of living in a comfortable home environment. Their ability to reach this goal comes from pitting they bold imagination against careful thinking. They consider and test out every design possibility, and work towards creating the ideal product experience. While they pursue perfection, they are also combining products with the democratization of consumer ideals so that everybody can have products that improve their lives. This is the goal they have been chasing from the start.

Kunlun Fight

Series B in 2016
Kunlun Fight, a Chinese sports company focused on organizing kickboxing matches.

Easyhin

Series B in 2016
Easyhin Technology is a combination of cross-border healthcare industry and the Internet industry, is committed to creating a new generation of Internet "health care." Tencent core team in both the products and the technical backbone of Ali, TOP Internet, but also in-depth understanding of Chinese healthcare industry, a senior 500 executives, as well as front-line services in the three large clinical specialist doctors. The company was awarded a top international VC investment, and users of the Internet thinking and ideas to create the best mobile baby health management services platform to mom.

Kunlun Fight

Series B in 2016
Kunlun Fight, a Chinese sports company focused on organizing kickboxing matches.

5miles

Series B in 2016
5miles LLC, founded in 2015 and headquartered in Dallas, Texas, operates an e-commerce platform that facilitates local buying and selling. The platform is designed to enhance the user experience by offering a straightforward and secure environment for transactions. Users can easily buy and sell a variety of items, including cars, furniture, and electronics, as well as local services such as beauty, auto repair, and home cleaning. The 5miles app streamlines the process, allowing individuals to list items by simply taking a photo and enabling seamless communication through comments. The platform is free to use, aiming to eliminate common issues found in other online marketplaces, such as high listing fees and the presence of fraudulent listings.

Musical.ly

Series B in 2015
Musical.ly, founded in 2014 by Alex Zhu and Luyu Yang, was a video social network that enabled users to create, share, and discover short videos, primarily catering to a teenage audience. The platform allowed users to express themselves through various forms of creativity, including singing, dancing, comedy, and lip-syncing, with videos limited to 15 seconds. Since its launch, Musical.ly gained significant popularity, becoming the top free app in the iOS App Store in 20 countries, including the United States. The app fostered a global community for content creators and users alike. In 2017, Musical.ly was acquired by a subsidiary of ByteDance, and in 2018, it was merged into TikTok, further expanding its reach and influence in the social media landscape.

Lele Ketang

Series B in 2015
LeLe Ketang offers online K-12 education services. The company focuses on primary school math and language. LeLe Ketang was founded in 2014 and is based in Beijing, China.

AGORAB2B

Series B in 2015
AGORA is a B2B e-commerce platform that offers expertise in the areas of B2B portal development. AGORA helps small and medium scale businesses in monitoring stock availability and goods prices, allowing businesses to make online reservations in the supplier's enterprise resource planning (ERP) software.

Hang

Series B in 2015
Agora, Inc. is a provider of Real-Time Engagement Platform-as-a-Service (RTE-PaaS) that enables developers to incorporate real-time video, voice, and messaging capabilities into their applications. Founded in 2013 and headquartered in Shanghai, the company offers a range of enterprise-grade products, including features for live interactive video and audio streaming, real-time messaging, and recording. Agora's solutions cater to various sectors such as social media, education, entertainment, gaming, healthcare, and financial services. The company operates a Software-Defined Real-Time Network, enhancing the delivery of its services across the globe. Additionally, Agora Lab, founded in 2014 and based in Palo Alto, California, focuses on developing real-time communication solutions, particularly in gaming and social networking. The Agora platform is recognized for its reliability and scalability, making it a widely adopted choice for organizations seeking efficient communication solutions.

Mioji Travel

Series B in 2015
Mioji uses big data and artificial intelligence to provide travel itinerary with only one click. Mioji collects millions of travel related websites in dozens of languages and build a structured database with billions of information node through semantic understanding. Mioji now provides products in flights, hotels, car rentals, and tickets for concerts and sports games.

Musical.ly

Series B in 2015
Musical.ly, founded in 2014 by Alex Zhu and Luyu Yang, was a video social network that enabled users to create, share, and discover short videos, primarily catering to a teenage audience. The platform allowed users to express themselves through various forms of creativity, including singing, dancing, comedy, and lip-syncing, with videos limited to 15 seconds. Since its launch, Musical.ly gained significant popularity, becoming the top free app in the iOS App Store in 20 countries, including the United States. The app fostered a global community for content creators and users alike. In 2017, Musical.ly was acquired by a subsidiary of ByteDance, and in 2018, it was merged into TikTok, further expanding its reach and influence in the social media landscape.

5miles

Series B in 2015
5miles LLC, founded in 2015 and headquartered in Dallas, Texas, operates an e-commerce platform that facilitates local buying and selling. The platform is designed to enhance the user experience by offering a straightforward and secure environment for transactions. Users can easily buy and sell a variety of items, including cars, furniture, and electronics, as well as local services such as beauty, auto repair, and home cleaning. The 5miles app streamlines the process, allowing individuals to list items by simply taking a photo and enabling seamless communication through comments. The platform is free to use, aiming to eliminate common issues found in other online marketplaces, such as high listing fees and the presence of fraudulent listings.

Redcore Times

Series B in 2015
By 2013, more people will be using their mobile devices than PCs to get online. As your prospect customers are browsing the Internet on the go with their iPhone, Android, iPad, etc, are you getting ready to keep up with the mobile trend and give your customers a wonderful mobile experience? Now we are on the mission to help you create your custom website to perfect people's mobile browsing experience across platforms and locations.

BIGO

Series B in 2015
BIGO Technology Pte. Ltd. is a rapidly expanding mobile Internet company based in Singapore, founded in 2014. It specializes in video broadcasting and VoIP-related products, leveraging advanced Artificial Intelligence technology to enhance user experience. The company offers a diverse range of applications, including Bigo Live for live streaming, Likee for short-form videos, and imo for messaging and voice calls. With a presence in over 150 countries and more than 400 million monthly active users, BIGO aims to foster connections among individuals by providing innovative platforms for self-expression and social interaction. The company operates more than 30 offices and six R&D centers globally, reinforcing its commitment to technology-driven growth and user engagement.
BDP (Business Data Platform) by a sea of production. Sea of ​​co-founded by former Baidu founding team members and executives, core team members from Baidu, Microsoft, IBM, EMC, Silicon Valley veteran Internet and IT experts, has received a number of top venture capital co-investment fund.

Huami

Series B in 2014
Launched in 2014, Huami is the top #1 wearable device company in the world, ahead of Apple and Fitbit, with over 50 million units sold. Huami's mission is to seamlessly connect biomechanical signals and daily activities with smart data services to promote healthy living and to make our lives easier. The product line of fashionable activity trackers and smartwatches under the Amazfit brand, including the Pace, Arc, Cor, Bip, Moonbeam and Equator, effortlessly track activity without sacrificing style. Huami is the exclusive provider of wearable technology for Xiaomi and maker of the Mi Band. Huami has raised $35 million from Sequoia Capital, Shunwei Capital Partners, Banyan Capital, Morningside Ventures and Xiaomi. The company is privately-held and headquartered in Beijing and and Mountain View, CA.

Guazi Car Rental

Series B in 2014
Guazi Car Rental is a Beijing-based P2P (peer to peer) car sharing platform. The platform allows private car owners to rent their vehicles to customers, in a model similar to the home sharing services provided by Airbnb.com. START was rebranded as Guazi Car Rental. Guazi Car Rental is operated in China.

DNAtrix

Series B in 2014
DNAtrix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in virus-driven immunotherapies for cancer treatment. The company develops modified viruses designed to selectively target and kill cancer cells, with its lead product, DNX-2401, focused on glioblastoma, an aggressive and currently incurable brain tumor. This oncolytic immunotherapy has shown promising early results, having been administered to over 35 patients. In addition to DNX-2401, DNAtrix is advancing other therapies, including DNX-2440 and DNX-2450 for solid tumors, and MYX-135 for hematological malignancies. The company aims to expand its platform technology to address a broader range of cancers, including brain metastases, ovarian, and pancreatic cancer. DNAtrix has formed a strategic partnership with Valo Therapeutics to enhance its research and development efforts.

WeDoctor

Series B in 2014
WeDoctor Holdings (Zhejiang) Co., Ltd. is a prominent medical and health technology platform based in Hangzhou, China, founded in 2010. The company specializes in developing solutions that utilize medical cloud and artificial intelligence technologies for various stakeholders, including governments, hospitals, and primary medical institutions. WeDoctor offers a range of services through its WeDoctor Cloud platform, which facilitates online and offline medical services, general practice, specialty consultations, and appointment registrations. Additionally, the company provides managed health services through WeDoctor HMO, aiming to enhance the medical care experience for users. With a mission to improve access to healthcare and promote overall wellness, WeDoctor strives to empower individuals and families through innovative healthcare solutions that integrate both digital and traditional services.

WeDoctor

Venture Round in 2014
WeDoctor Holdings (Zhejiang) Co., Ltd. is a prominent medical and health technology platform based in Hangzhou, China, founded in 2010. The company specializes in developing solutions that utilize medical cloud and artificial intelligence technologies for various stakeholders, including governments, hospitals, and primary medical institutions. WeDoctor offers a range of services through its WeDoctor Cloud platform, which facilitates online and offline medical services, general practice, specialty consultations, and appointment registrations. Additionally, the company provides managed health services through WeDoctor HMO, aiming to enhance the medical care experience for users. With a mission to improve access to healthcare and promote overall wellness, WeDoctor strives to empower individuals and families through innovative healthcare solutions that integrate both digital and traditional services.

Maimai

Series B in 2014
Maimai is a China-based career and social-networking platform founded in 2013 by Lin Fan. It now has tens of millions of users and surpasses LinkedIn in China for most used professional social networking site.

Aihuishou

Series B in 2014
Aihuishou.com (爱回收网) is a bidding-based C2B platform for recycling and the sale of selling second-hand electronic items such as mobile phones, laptops, and more. At present, the recyclable mobile categories are more than 30, including Apple, HTC, Motorola, Samsung, and Sony Ericsson. It nearly covers all the popular mobiles in the market and works in the form of bidding purchase, avoiding the possibility of over-low price assessment of second-hand mobile phones and other second-hand electronic products. It facilitates the purchasing of second-hand electronic products of companies and individuals at the highest price, providing users with a one-stop disposal service of idle items, and making contributions to the environmental protection course.

Nice

Series B in 2014
Nice allows users to add labels, stickers and screens to photos that they share on social networks. It currently has close to 10 million registered users. First launched in October 2013 by a team of fashionistas turned developers, nice soon found a niche of like-minded users who enjoyed tagging their clothes with the app. Touted as "China's Instagram", Nice has become the leading photo sharing app in mainland China. Nice has a very active and young audience and also has steady international growth, with multi-lingual interface options available in its settings.

Synchroneuron

Series B in 2014
Synchroneuron Inc. is a biopharmaceutical company focused on developing therapies for tardive dyskinesia and other neuropsychiatric disorders. Its lead candidate, SNC-102, is a sustained-release formulation of acamprosate calcium that aims to enhance pharmacokinetic properties compared to existing formulations. SNC-102 is designed to address tardive dyskinesia by modulating both excitatory and inhibitory neurotransmission in the neural circuits responsible for involuntary movements. The drug is currently undergoing evaluation in phase 2 trials for tardive dyskinesia and Tourette syndrome, as well as in phase 1 trials for combat-related posttraumatic stress disorder. Founded in 2011 and based in Duxbury, Massachusetts, Synchroneuron was previously known as Eukinetix, Inc.

Kuaishou

Series B in 2014
Beijing Kuaishou Technology Ltd. develops Kuaishou, an online video and photo sharing application launched in 2011. As one of the leading short video social platforms globally, Kuaishou has over 200 million daily active users and features 15 million user-generated content pieces uploaded daily. The platform aims to enhance individual happiness through the use of big data and artificial intelligence and is designed to showcase the diverse and often overlooked communities of China. Kuaishou enables users to share short videos, photos, and livestreams, fostering connections among people from various backgrounds. This approach allows ordinary citizens to engage with a global audience, offering a glimpse into their lives. The international counterpart, Kwai, mirrors Kuaishou's features while incorporating localized functions for users outside of China. With an extensive archive of 10 billion original short videos and 350 million daily likes, Kuaishou continues its mission to document human experiences and empower individuals worldwide.

Yooli

Series B in 2014
Yooli.com Inc. operates a person-to-person crowdfunding platform that facilitates loans for borrowers. Founded in 2012 and based in Beijing, China, Yooli collaborates with 23 offline micro-credit companies to provide investors with access to loans sourced from various smaller peer-to-peer platforms. To enhance trust and confidence in its offerings, Yooli partners with a third party to evaluate the credit quality of each loan, ensuring a more reliable investment environment for its users.

Xiaozhu.com

Series B in 2014
Xiaozhu.com (小猪短租网) is a Chinese booking website for daily rental and short-term rooms. It aims to provide a guaranteed platform for online communication and transactions for landlords and tenants. Also, a green platform ecosystem is established by mechanisms such as property and personal safety guarantee schemes as well as identification. This will effectively take full advantages and maximize the value of landlords' idle resources through sharing. Meanwhile, it enhances the social relationship and interaction between landlords and tenants and provides tenants with more humanized accommodation experience which is different from traditional hotels. Currently, the company has had branches in 13 cities all over the country and its house sources cover more than 130 domestic cities.

Senhwa Biosciences

Series B in 2013
Senhwa Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative cancer therapies. Founded in 2012 and headquartered in New Taipei City, Taiwan, the company is advancing several drug candidates through clinical trials. Notably, CX-4945 is undergoing phase I/II trials for cholangiocarcinoma in combination with gemcitabine and cisplatin, while CX-5461 is being tested in phase I studies for advanced hematologic malignancies and solid tumors, including breast cancer. Additionally, CX-4945 is involved in trials for advanced basal cell carcinoma and recurrent SHH medulloblastoma through pediatric brain tumor consortium studies. Senhwa Biosciences aims to identify and develop therapies that have the potential to significantly enhance treatment outcomes for patients, focusing on underexploited targets that could improve the standard of care.

ASLAN Pharmaceuticals

Series B in 2013
ASLAN Pharmaceuticals is a clinical-stage biopharmaceutical company based in Singapore, specializing in immunology and oncology. Founded in 2010, the company focuses on developing innovative treatments aimed at improving patient outcomes. Its clinical portfolio includes ASLAN004, a monoclonal antibody therapy for atopic dermatitis and other immunological conditions, as well as small molecule inhibitors targeting various cancer types. ASLAN collaborates with notable partners such as Almirall, Array BioPharma, Bristol-Myers Squibb, and CSL Limited to enhance its research and development efforts. The company is dedicated to creating novel medicines for both Asian and global markets.